Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome–Coronavirus Spike Protein

Published on
Journal: Nanoscale
[저자] Matthijs P Raadsen, Christine Dahlke, Anahita Fathi, Mart M Lamers, Petra van den Doel, Luca M Zaeck, Martin E van Royen, Erwin de Bruin, Reina Sikkema, Marion Koopmans, Eric C M van Gorp, Gerd Sutter, Rory D de Vries, Marylyn M Addo, Bart L Haagmans
[Category] update2024,
PMC URL    Pubmed URL    DOI URL    [DOI] 10.1093/infdis/jiad052    
[Article Type] Brief Report
[Source] PMC

A modified vaccinia virus Ankara–based candidate vaccine against Middle East respiratory syndrome–associated coronavirus elicits monkeypox virus neutralizing antibodies after 3 doses in healthy clinical trial participants.

All Keywords
【저자키워드】 modified vaccinia virus Ankara, Monkeypox virus, MVA, MPXV, Middle East respiratory syndrome–related coronavirus,